Catherine Kevane

Catherine Kevane

Fenwick & West LLP

Contact  |  View Bio  |  RSS

Latest Publications


Baby You Can Drive My Car… Or Corporate Jet: SEC Scrutiny of Executive Compensation Perks Disclosures

The SEC continues to focus on accounting and disclosure violations, including in the area of executive perks disclosure in corporate proxy statements. In the past year, the SEC brought two enforcement cases against executives...more

11/24/2015 - Corporate Fraud Disclosure Requirements Enforcement Actions Executive Compensation Proxy Statements SEC

Not a Coin Toss: Regulatory Agencies Bringing Enforcement Actions Against Virtual Currency Start-ups

The Commodity Futures Trading Commission (“CFTC”) and the SEC are flexing their regulatory muscles to rein in securities and commodities rules violations by start-up companies in the virtual currency space. On September 17,...more

11/23/2015 - Bitcoin CFTC Commodities Exchange Act Enforcement Actions Popular SEC Swaps Virtual Currency

Securities Litigation and Enforcement Newsletter

In this our second edition of Fenwick’s Securities Litigation and Enforcement Newsletter, we continue to provide you with short insights about timely securities litigation and enforcement developments. This edition’s topics...more

11/20/2015 - Cell Phones Cybersecurity D&O Insurance Disclosure-Based Settlements Enforcement Actions Executive Compensation Fifth Amendment SEC Virtual Currency

You’re the Man—Government Targets Individuals in FCPA Cases

The government has increasingly focused its FCPA enforcement firepower on individuals. On August 31, a Russian official living in Maryland pled guilty to conspiracy to commit money laundering in connection with arranging $2...more

9/24/2015 - Bank of New York (BNY) Mellon Compliance Corporate Misconduct Criminal Conspiracy Defense Contracts DOJ FCPA Foreign Official Goodyear Guilty Pleas Internships Money Laundering Personal Liability SEC

Matchmaker, Matchmaker Make me a… 506(b) Private Placement Investment

The SEC has given the go-ahead to a venture capital firm’s plan to conduct 506(b) private placements online. On August 5, 2015, the Commission issued a no-action letter to Citizen VC, Inc., saying the firm’s proposed online...more

9/23/2015 - Broker-Dealer Compliance Financial Institutions Financial Markets Investment Investment Portfolios Investors No-Action Letters Online Platforms Private Placements Regulation D Rule 506(c) SEC Securities Exchanges Venture Capital

“You Know How to Whistle Don’t You?”—Whistleblowers Gain Even More Protection

The SEC recently issued guidance specifying that whistleblowers do not first have to take their concerns to the SEC in order to be covered by the SEC’s anti-retaliation rule. The guidance clarifies that those whistleblowers...more

9/22/2015 - Anti-Retaliation Provisions Barnes and Noble Confidentiality Agreements Enforcement Actions Internal Investigations Internal Reporting KBR (formerly Kellogg Brown & Root) Retaliation SEC Securities Fraud Whistleblowers White Collar Crimes

Return of the Cyborg—FTC and SEC Oversight of Cybersecurity Ramps Up

The government appears to be increasing its enforcement efforts regarding cybersecurity risks. A three-judge panel of the U.S Court of Appeals for the Third Circuit recently held the FTC may bring a claim that a company’s...more

9/21/2015 - Cyber Attacks Cyber Crimes Cybersecurity Data Breach Data Security Disclosure Requirements Enforcement Actions Federal Trade Commission Act FTC Hackers Publicly-Traded Companies SEC Section 5 Target Unfair or Deceptive Trade Practices

SEC Announces $30 Million Whistleblower Award to Non-U.S. Resident

On Monday, September 22, 2014, the SEC announced that it expected to award between $30 and $35 million to a non-U.S. whistleblower who provided the SEC with information about “an ongoing fraud that would have been very...more

9/29/2014 - Chief Compliance Officers Dodd-Frank FCPA Foreign Nationals Fraud Risk Assessment Risk Management SEC Whistleblower Awards

Securities Litigation Alert: GlaxoSmithKline and Five Executives Convicted of Bribery in China

On Friday, September 19, 2014, a Chinese court found pharmaceutical giant GlaxoSmithKline guilty of bribing doctors and hospitals in order to increase sales of the company’s products in China. Among other things, the company...more

9/26/2014 - Bribery China Foreign Nationals Foreign Official GlaxoSmithKline Hospitals Physicians White Collar Crimes

Securities Litigation Alert: DOJ and SEC Issue Joint Guidance on FCPA

The past several years have seen a dramatic increase in the number of enforcement actions brought by the Department of Justice (DOJ) and the Securities and Exchange Commission (SEC) under the Foreign Corrupt Practices Act...more

11/16/2012 - Compliance DOJ FCPA FCPA Resource Guide SEC

11 Results
View per page
Page: of 1

"My best business intelligence, in one easy email…"

Your first step to building a free, personalized, morning email brief covering pertinent authors and topics on JD Supra:

Sign up to create your digest using LinkedIn*

*By using the service, you signify your acceptance of JD Supra's Privacy Policy.
*With LinkedIn, you don't need to create a separate login to manage your free JD Supra account, and we can make suggestions based on your needs and interests. We will not post anything on LinkedIn in your name. Or, sign up using your email address.